Benzinga

Benzinga

Benzinga

lunes, agosto 31

Orchestra BioMed Holdings Inc

OBIONASDAQ
Trade with Public
Trade with Public
$5.04
-0.14-2.8%
al cierre: Aug 31, 5:00 PM EST
$5.11
0.07181.42%
After hour: 7:02 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Orchestra BioMed Hldgs Financials

Orchestra BioMed Hldgs (OBIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Orchestra BioMed Hldgs Q2 EPS $(0.38) Misses $(0.37) Estimate, Sales $88.000K Miss $121.400K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.37) by 2.7 percent. This is a 24 percent increase over losses of $(0.50) per share
Benzinga Newsdesk

PRO
Orchestra BioMed Hldgs Q1 EPS $(0.33) Beats $(0.41) Estimate, Sales $110.000K Miss $190.750K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41) by 19.51 percent. This is a 32.65 percent increase over losses of $(0.49) per share
Benzinga Newsdesk

PRO
Orchestra BioMed Hldgs Q4 EPS $0.26 Beats $(0.39) Estimate, Sales $30.917M Beat $878.600K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $(0.39) by 166.16 percent. This is a 160.47 percent increase over losses of $(0.43) per
Benzinga Newsdesk

PRO
Orchestra BioMed Hldgs Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $861.000K Beat $757.600K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 5.21 percent. This is a 2.44 percent increase over losses of $(0.41) per share
Benzinga Newsdesk

PRO
Orchestra BioMed Hldgs Q2 EPS $(0.50) Beats $(0.51) Estimate, Sales $836.000K Beat $695.600K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.51) by 0.99 percent. This is a 11.11 percent decrease over losses of $(0.45) per share
Benzinga Newsdesk

PRO
Orchestra BioMed Hldgs Q1 EPS $(0.49) Misses $(0.48) Estimate, Sales $868.00K Beat $575.80K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 28.95 percent decrease over losses of $(0.38) per
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved